CurrentRheuma
Get Weekly

Topic · page 2 of 47

Lupus & antiphospholipid syndrome

Systemic and cutaneous lupus erythematosus, lupus nephritis, neuropsychiatric lupus, disease activity, remission and low disease activity, damage, antimalarials and targeted treatment; antiphospholipid antibodies and antiphospholipid syndrome, thrombotic and obstetric

Briefs 41–80 of 1,848 placed here, newest publication first

Briefs in Lupus & antiphospholipid syndrome

Newest publication first

  1. Lupus Sci Med

    Interleukin-22 reflects adverse cardiometabolic features in SLE

    Cross-sectional study

  2. Lupus Sci Med

    Diagnostic accuracy of the Arabic composite autonomic symptom score 31 (COMPASS-31) for detecting autonomic neuropathy in SLE: a cross-sectional validation study

    Diagnostic or prognostic study

  3. Lupus Sci Med

    Protein biomarkers of inflammation in women with SLE and their newborn children

    Cross-sectional study

  4. Lupus

    High burden and unique pattern of cerebral small vessel disease in antiphospholipid syndrome: MRI subtypes and risk profile in a large cohort

    Cohort study

  5. Lupus

    Association of serum levels of galectin-9 and IP-10 with disease activation in lupus nephritis

    Cross-sectional study

  6. Lupus

    Burden of herpes zoster and recombinant zoster vaccine willingness in systemic lupus erythematosus: A single-center cohort study

    Cohort study

  7. Lupus

    Lupus nephritis at systemic lupus erythematosus onset and kidney outcomes in a Latin American biopsy-proven cohort

    Cohort study

  8. RMD Open

    Clinical and immunological outcomes of rituximab-based, mycophenolate mofetil-based and cyclophosphamide-based treatment strategies for systemic lupus erythematosus with active kidney involvement from LOOPS registry

    Cohort study

  9. Lupus Sci Med

    Childhood trauma and systemic lupus erythematosus activity in Tunisian patients: exploring the mediating role of post-traumatic stress disorder

    Cross-sectional study

  10. Lupus Sci Med

    National trends in hospitalisation, in-hospital mortality and resource use for SLE in Spain from 2016 to 2022

    Cross-sectional study

  11. RMD Open

    Evaluating a guideline-aligned prednisone threshold within the Lupus Low Disease Activity State (LLDAS): associations with damage accrual

    Cohort study

  12. RMD Open

    Early SLE may follow a fast comorbidity/multimorbidity trajectory associated with flare burden and glucocorticoid exposure

    Cohort study

  13. Lupus Sci Med

    Nursing interventions for people with systemic lupus erythematosus: a systematic review

    Meta-analysis

  14. Lupus Sci Med

    Inhibition of STING modulates dendritic cell responses and ameliorates podocyte injury in SLE

    Mechanistic study

  15. Lupus Sci Med

    Evaluating the reliability and quality of lupus nephritis educational content on TikTok and Bilibili: a cross-sectional content analysis

    Cross-sectional study

  16. Arthritis Care Res (Hoboken)

    Prevalence of Dietary Supplement Use and Potential Medication Interactions Among Adults With Systemic Lupus Erythematosus

    Cross-sectional study

  17. Lupus Sci Med

    Comparison of cardiac MRI features of fibrosis and strain for early cardiac dysfunction assessment in patients with systemic lupus erythematosus and Sjögren’s syndrome

    Cross-sectional study

  18. Lupus Sci Med

    Long-term outcomes and treatments for proliferative lupus nephritis with low-level proteinuria: a multicentre retrospective study in Japan

    Cohort study

  19. Lupus Sci Med

    Measurement properties of the FATIGUE-PRO in patients with SLE in real-world settings

    Diagnostic or prognostic study

  20. Arthritis Rheumatol

    Comparative Safety of Common Immunosuppressant Therapies in Systemic Lupus Erythematosus: A Target Trial Emulation Study

    Research article

  21. Lupus Sci Med

    Risk of stroke in SLE: a systematic review and meta-analysis

    Meta-analysis

  22. Lupus Sci Med

    Racial differences in cardiovascular events and adverse pregnancy outcomes among pregnant individuals with SLE

    Cohort study

  23. Rheumatology (Oxford)

    Remission, low disease activity and relapse in patients with juvenile-, adult- and late-onset SLE

    Cohort study

  24. Semin Arthritis Rheum

    Multimodal brain MRI abnormalities in systemic lupus erythematosus and their association with disease activity and neuropsychiatric involvement: a systematic review

    Meta-analysis

  25. Semin Arthritis Rheum

    Peripheral macrovascular thrombosis in catastrophic antiphospholipid syndrome (CAPS): A descriptive analysis from the “CAPS Registry”

    Cross-sectional study

  26. Semin Arthritis Rheum

    Lessons from a specialized lupus clinic: Presentation and damage outcomes in inception vs. prevalent lupus nephritis cohorts

    Cohort study

  27. Lupus Sci Med

    Long-term association of the triglyceride-glucose index with cardiovascular involvement in systemic lupus erythematosus: a retrospective cohort study

    Cohort study

  28. Lupus Sci Med

    Integrated metabolomics and DNA methylation signatures and their association with flare remission in SLE

    Cohort study

  29. Lupus Sci Med

    Identification and functional characterisation of SCO1 as a mitochondria-related biomarker in lupus nephritis

    Mechanistic study

  30. Lupus Sci Med

    Efficacy and safety of telitacicept combined with standard of care in patients with proliferative lupus nephritis: a real-world retrospective study

    Cohort study

  31. Lupus Sci Med

    Unveiling the molecular and immune heterogeneity across distinct disease activity states of systemic lupus erythematosus through integrative bulk and single-cell transcriptomics

    Mechanistic study

  32. Rheumatology (Oxford)

    Macrophage activation syndrome in systemic lupus erythematous and Still’s disease: distinct phenotypes shaped by the underlying diseases

    Cohort study

  33. Lupus

    Global prevalence and associated factors of metabolic syndrome in patients with systemic lupus erythematosus: A systematic review and meta-analysis

    Meta-analysis

  34. Arthritis Rheumatol

    A Coding Single‐Nucleotide Polymorphism in β 2 ‐Glycoprotein I ( APOH ) Is Associated With Increased Autoantibody Levels but Reduced Venous Thromboembolism Risk

    Research article

  35. Lupus

    Views on pregnancy and related concerns among women with systemic lupus erythematosus: A cross-sectional study

    Cross-sectional study

  36. Arthritis Rheumatol

    CASTOR1 Regulates Humoral Immune Responses and Contributes to the Pathogenesis of Systemic Lupus Erythematosus

    Mechanistic study

  37. Lupus

    Clinical characteristics of patients with primary antiphospholipid syndrome and “single” antiphospholipid antibody: Retrospective results from the APS ACTION clinical database and repository (“registry”)

    Cohort study

  38. Lupus Sci Med

    Development and temporal validation of a clinical prediction model to identify bacterial infection in hospitalised patients with systemic lupus erythematosus

    Diagnostic or prognostic study

  39. Lancet Rheumatol

    Derivation, validation, and proposed thresholds of the Lupus Arthritis and Musculoskeletal Disease Activity (LAMDA) instrument: a cohort study

    Cohort study

  40. Lupus Sci Med

    Genetic and epigenetic determinants of relapse risk in lupus nephritis

    Cohort study

All 1,848 Briefs in ExploreShowing Briefs 41–80 of 1,848, newest first